CRDF · Company research
Cardiff Oncology, Inc. Common Stock (CRDF): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| CRDF Oct 2026 1.500 put (CRDF261016P00001500) Stock Price, News, Quote & History - Yahoo! Finance Canada | CRDF Oct 2026 1.500 put (CRDF261016P00001500) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 14, 2026 | neutral | 0 | 0.6 |
| SKYW,TMUS,TBBK,SCHW,DOC,CHTR,MANH,MRSH,CRDF | Stock Prices | Quote Comparison - Yahoo! Finance Canada | SKYW,TMUS,TBBK,SCHW,DOC,CHTR,MANH,MRSH,CRDF | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 5, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology Inc (CRDF) Stock Price Target & Forecast - TradingKey | Cardiff Oncology Inc (CRDF) Stock Price Target & Forecast TradingKey | View source ↗ | TradingKey | Sep 29, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology Inc (NASDAQ: CRDF) Share Price, CRDF Stock News, CRDF Share Price & Updates - Kalkine | Cardiff Oncology Inc (NASDAQ: CRDF) Share Price, CRDF Stock News, CRDF Share Price & Updates Kalkine | View source ↗ | Kalkine | Sep 28, 2026 | neutral | 0 | 0.6 |
| $CRDF stock is up 7% today. Here's what we see in our data. - Quiver Quantitative | $CRDF stock is up 7% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 15, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit - Slideshow - Seeking Alpha | Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit - Slideshow Seeking Alpha | View source ↗ | Seeking Alpha | Sep 10, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology will take part in two September cancer conferences - Stock Titan | Cardiff Oncology will take part in two September cancer conferences Stock Titan | View source ↗ | Stock Titan | Sep 2, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology (NASDAQ: CRDF) seeks share boost that may dilute holders - Stock Titan | Cardiff Oncology (NASDAQ: CRDF) seeks share boost that may dilute holders Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| $CRDF stock is up 14% today. Here's what we see in our data. - Quiver Quantitative | $CRDF stock is up 14% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 24, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update - Stock Titan | Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update Stock Titan | View source ↗ | Stock Titan | Aug 11, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology Raises $10M for Onvansertib Regulatory Push - AllSci | Cardiff Oncology Raises $10M for Onvansertib Regulatory Push AllSci | View source ↗ | AllSci | Jul 16, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $CRDF Buys 687,285 Shares | CRDF Stock News - Quiver Quantitative | Insider Purchase: Director at $CRDF Buys 687,285 Shares | CRDF Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 16, 2026 | neutral | 0 | 0.6 |
| Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential? - Yahoo Finance | Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| CRDF Forecast — Price Target — Prediction for 2027 - TradingView | CRDF Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| New colorectal cancer drug combo shows 72% response in trial - Stock Titan | New colorectal cancer drug combo shows 72% response in trial Stock Titan | View source ↗ | Stock Titan | Jun 2, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology (CRDF) Files Lawsuit Against Nerviano Medical S - GuruFocus | Cardiff Oncology (CRDF) Files Lawsuit Against Nerviano Medical S GuruFocus | View source ↗ | GuruFocus | Jun 1, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist - Simply Wall Street | Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist Simply Wall Street | View source ↗ | Simply Wall Street | May 20, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal Cancer - Seeking Alpha | Cardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal Cancer Seeking Alpha | View source ↗ | Seeking Alpha | Apr 6, 2026 | neutral | 0 | 0.6 |
| Cardiff Oncology, Inc. Common Stock (CRDF) Stock Price: Oct 7 Close $1.09 - Gotrade | Cardiff Oncology, Inc. Common Stock (CRDF) Stock Price: Oct 7 Close $1.09 Gotrade | View source ↗ | Gotrade | Feb 2, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.